GlaxoSmithKline (GSK) has entered into a significant partnership with LTZ Therapeutics to develop innovative treatments targeting hematologic cancers and solid tumors. This collaboration will leverage LTZ’s...
A significant investment in cancer research has taken shape in Canada, with a generous donation of $5 million from the late Archie and Irene Verspeeten, allocated...